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Abstract
Background: Homozygous protein C (PC) deficiency is a potentially fatal disease with ocular blinding presentation
or sequela.
Case presentation: A 5month-old boy was presented for evaluation of leukocoria. He had a history of frequent
bruises and PC deficiency, treated with warfarin.
His intraocular pressure was normal. In the left eye leukoma with anterior segment dysgenesis, shallow anterior
chamber, and cataract were observed. Fundus was not visible. B-scan revealed a closed funnel retinal detachment.
His right eye had a normal anterior segment and a thin retina with anomalous retinal vascular branching at equator
and peripheral retina. A fibrovascular tuft on the optic nerve head with induced traction on superior arcade was
visible. Total loss of a and b wave of both were appreciated in electroretinography (ERG). Fluorescein angiography
(FA) showed very severe leakage at the junction of the vascularized and non-vascularized retina and optic nerve
head. Favorable outcome was achieved with lasering of avascular retina in the right eye.
Conclusion: The potential for protein C deficiency should be assessed in all infants with leukocoria, anterior
segment dysgenesis, retinal detachment and retinal dysplasia. Early diagnosis could save the child’s life and vision.
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Background
Protein C (PC), first described by Stenflo in 1976, is a
vitamin K dependent anticoagulant enzyme that inacti-
vates the plasma factors Va and VIIIa by limited prote-
olysis, thereby inhibiting the conversion of factor X to
factor Xa and of prothrombin to thrombin [1]. Heredi-
tary (congenital) PC deficiency is a rare autosomal dis-
order that predisposes to potentially blinding and fatal
thromboembolic attacks [2]. Homozygotes have very low
or undetectable PC activity (usually less than 1%, normal
70–140%) and do present within the first few days of life
[2]. Heterozygotes have about 50% levels of PC and usu-
ally remain asymptomatic until adolescence or adult-
hood. Neonatal PC deficiency may also be acquired and
transient, especially in preterm ill infants [3] with subse-
quent thrombosis being as severe as in the homozygous
condition. Herein, we present a case of congenital PC
deficiency with asymmetric ophthalmic manifestations.
Fluorescein angiography (FA) and electroretinography
(ERG) have been performed. The better eye was treated
with indirect laser and the vision was saved.
Case presentation
The patient was a full term Iranian male that was deliv-
ered with normal labor and was the first child of first
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cousin parents. He was presented on his third day of life
with a purpura area on his buttocks and abdomen.
Very low protein C activity (less than 8%) was con-
firmed in the laboratory investigations and the patient
was treated with fresh frozen plasma (FFP) and anti-
coagulant therapy (warfarin).
Both parents had low level of PC activity (52% in
father and 60% in mother.). Liver and renal function
tests were normal and no organomegaly or lymphaden-
opathy was observed. After 5 months, in his first oph-
thalmic examination, leukocoria was detected and
evaluated. The child was on warfarin therapy with no
more hypercoagulability state. The examination under
anesthesia was conducted at Farabi Hospital for further
assessment.
Both eyes had normal intraocular pressure (IOP). He
had eye-to-eye contact in the right eye but he couldn’t
fix and follow in left eyes.
His right eye had a normal anterior segment with
round and reactive pupil. He had a central corneal
leukoma on his left eye with a distorted pupil, total
posterior synechia, dilated iris radial vessels, flat anterior
chamber and mature membranous cataract. The right
eye had a normal anterior segment, on a fundoscopy, a
thin retina with anomalous retinal vascular branching
and fading arterioles and venules was observed at equa-
tor and thereafter. (Fig. 1, a-h) There was a fibrovascular
tuft on the optic nerve head with an induced traction on
superior arcade. At the B-scan, the left eye had a closed
funnel shaped retinal detachment. Electroretinography
(ERG) elucidated complete loss of a and b wave of both
eyes. Fluorescein angiography (FA) has shown very se-
vere leakage at the vascularized and non-vascularized
borders of the fundus and at the optic nerve head of the
right eye. Severe patchy and stippled abnormal skin
fluorescence (on the face, thorax, back, buttocks, and
limbs) was observed at the time of FA. (Fig. 1, d-h) In-
direct laser has been applied to the avascular areas.
The skipped areas were lasered during consecutive
monthly follow-up visits and the neovascularizations
were gone. The patient was followed-up for a total of 28
months with a favorable outcome, as no new ocular or
Fig. 1 Ocular findings of a patient with homozygous congenital protein C deficiency. a In the right eye thin dysplastic retina and peripheral
avascularization with a fibrovascular band from optic disc to superior arcade is visible (arrow). b In the left eye leukoma and irregular pupil with
posterior synechia and dilated iris vessels and cataract is visible. c Total funnel shaped retinal detachment of left eye is visible in B-scan (arrow). d
and e Splinter and patchy abnormal fluorescences of the skin at the time of fluorescein angiography are shown (arrow). f-h Fluorescein
angiography with early leakage (arrow) from mid-peripheral vessels all over the retina and later leakage around the optic nerve head due to the
tractional effect of fibrovascular band. The leakage increases during less than 1 min with severe vitreous fluorescence
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systemic findings were detected. He had eye-to-eye con-
tact and fix and follow vision in the right eye but no fix
and follow vision in the left eye.
Discussion and conclusions
Herein, we described a case of homozygote PC deficiency
with severe asymmetric anterior and posterior segment
dysgenesis. His right eye was rescued from the inevitable
blindness of the future. The disadvantages of this report
include the poor co-operation during ERG and FA (due to
a young age) and the lack of genetic testing.
Activated PC prevents the formation of blood clots by
down-regulating the coagulation cascade and blocking
the spread of thrombosis [4]. Phenotypically, two types
of PC deficiency have been described: type I, with re-
duced both antigenic and functional levels, and type II
deficiency with reduced PC activity and normal antigenic
concentration. Type I heterozygous cases comprise 76%
of cases and homozygous type I comprise only 5% of
cases with severe ocular and systemic findings. 4 Homo-
zygous PC deficiency is rare with an estimated incidence
of 1 in 500,000 to 1 in 750,000 [4]. It presents 2 h to
months after birth, or with delayed symptoms, with life
threatening thromboses involving the central nervous
system, eyes, kidneys, and skin (purpura fulminans) [5].
Management is carried out in the acute phase with intra-
venous PC concentrate (ImmunoAG, Vienna, Austria),
FFP and anticoagulators [5]. Untreated cases usually lead
to death [5].
Ophthalmic manifestations include non-reactive pu-
pils, leukocoria, chemosis, periorbital edema, shallow an-
terior chamber, dilated iris vessels, posterior synechia
and microphthalmos. Posterior segment findings include
vitreous, retinal and subretinal hemorrhage, retinal arter-
ial and venous occlusion and retinal dysplasia [2].
One or both of the eyes may be affected. (Table 1)
Leukocoria alone may be the first manifestation of
homozygous PC deficiency, even before any other sys-
temic manifestations such as purpura fulminans [17].
Early treatment may result in a better visual prognosis
[17]. Likewise, homozygous PC deficiency can lead to
thrombosis of the cavernous sinus and other cranial
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vessels [28]. These ocular complications may occur as
antenatal or postnatal events [28].
Systemic manifestations are purpura fulminans, hema-
tomas; epistaxis; prolonged bleeding; hydrocephalus;
subarachnoid hemorrhage; pulmonary embolism; throm-
botic hemorrhagic gastrointestinal and genitourinary
mucosal infarctions of renal and deep vein thrombosis
with the pulmonary embolism and candida sepsis [28].
These lesions usually cause death if they are not treated.
Approximately 20 case reports of PC deficiencies with
ocular involvement have been published since the first
patient was described in 1981. (Table 1).
The casual association of PC deficiency and retinal
dysplasia may be the case in our patient. A thrombosis
of the fetal hyaloid arterial system and partial or
complete microvascular occlusions at a crucial develop-
mental stage may underlie the developmental eye path-
ology. Our patient had bilateral asymmetric
involvement, and more specifically, avascularization and
peripheral vascular leakage in the better eye and total
funnel detachment in the other eye. This is the third bi-
lateral asymmetric case reported and the only case with
fluorescein angiography. The interesting problem in our
case was the patchy severe fluorescence of some parts of
the skin that was observed at the time of fluorescein
angiography. Lasering of the avascular retina prevented
the baby from being completely blind. Mosnier et al.
documented the additional effect of protein C in on the
cytoprotective pathway mediated by a separate mechan-
ism than its anticoagulant role [29]. Maintaining the
endothelial barrier and anti-apoptotic activity of the PC
in this pathway [29] and vascularization arrest of retina
may have some effects on retinal dysplastic changes. In
some of the described patients, persistent primary hyper-
plastic vitreous (PHPV) and microphthalmia have been
reported. (Table 1) Vitreoretinopathy in both eyes pro-
posed retinal dysplasia rather than PHPV [21]. Depend-
ing on the time at which vascular insults occur within
the ocular system during the embryonic developmental
phase, different presentations of the anterior segment
and /or posterior segment would follow. Despite
complete treatment, the process of ocular changes could
be progressive as seen in corneal opacity [21]. Wang
et al. reported association of PC deficiency with other
hypercoagulability states as protein S and antithrombin
III deficiency, as well as borderline hypothyroidism [24].
We have not seen such an association.
We therefore conclude that unilateral or bilateral
infantile ocular findings such as leukocoria and retinal
detachments and dysplasia may be the first manifesta-
tions of homozygous PC deficiency. In addition, by
paying attention to the possible asymmetric nature of
the ocular manifestation, vision can be protected to
some degree. Physicians should be aware of these
problems, as these infants may also have severe cere-
bral and internal vital organ complications that are
preventable, if they are treated on time. The possible
effect of natural blood anticoagulants (such as PC) on
the development of the anterior and posterior seg-
ments of the eye during or after fetal development
has yet to be defined.
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